Literature DB >> 11804663

Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase.

Carl M Oneta1, Charles S Lieber, JunJie Li, Sigmund Rüttimann, Beat Schmid, Jürg Lattmann, Alan S Rosman, Helmut K Seitz.   

Abstract

BACKGROUND/AIMS: Chronic ethanol consumption results in the induction of hepatic cytochrome P4502E1 (CYP2E1) in man, which is believed to play an important role in the pathogenesis of alcoholic liver disease. However, the amount and duration of alcohol intake associated with CYP2E1 induction is not known but limited information is available on the disappearance of CYP2E1 following alcohol withdrawal.
METHODS: To study these questions, five healthy male volunteers received ethanol daily (40 g/day) over 4 weeks. CYP2E1 induction was monitored by using the chlorzoxazone test before and every week following the start of alcohol ingestion. In addition, CYP2E1 was also determined in five alcoholics 1, 3, 8 and 15 days following ethanol withdrawal and in five patients with non-alcoholic liver disease.
RESULTS: A significant CYP2E1 induction occurred 1 week following the ingestion of 40 g ethanol per day and increased further after 4 weeks. The disappearance of CYP2E1 was found to be significant 3 days following ethanol withdrawal and further decreased up to day 8. Thereafter, no significant change occurred and CYP2E1 activities were comparable with those in patients with non-alcoholic liver disease.
CONCLUSIONS: These data show a significant and quick induction of CYP2E1 activity, already at moderate alcohol consumption, which may be of importance in the pathogenesis of alcoholic liver disease, of ethanol, drug and vitamin A interactions and in alcohol associated carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804663     DOI: 10.1016/s0168-8278(01)00223-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

1.  Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses.

Authors:  Nicolas Hohmann; Antje Blank; Jürgen Burhenne; Yosuke Suzuki; Gerd Mikus; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2019-08-09       Impact factor: 4.335

2.  Ultra-rapid rate of ethanol elimination from blood in drunken drivers with extremely high blood-alcohol concentrations.

Authors:  Alan Wayne Jones
Journal:  Int J Legal Med       Date:  2007-06-16       Impact factor: 2.686

Review 3.  Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment.

Authors:  Cristina Rodriguez-Antona; Alvin Gomez; Maria Karlgren; Sarah C Sim; Magnus Ingelman-Sundberg
Journal:  Hum Genet       Date:  2009-10-08       Impact factor: 4.132

4.  Obesity-induced CYP2E1 activity in children.

Authors:  Christina Gade; Kim Dalhoff; Tonny Petersen; Troels Riis; Camilla Schmeltz; Elizaveta Chabanova; Hanne Rolighed Christensen; Gerd Mikus; Juergen Burhenne; Jens Christian Holm; Helle Holst
Journal:  Br J Clin Pharmacol       Date:  2018-12-09       Impact factor: 4.335

5.  CYP2E1 activity and children with obesity: possible confounding factors.

Authors:  Hardeep Kaur; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Br J Clin Pharmacol       Date:  2018-10-17       Impact factor: 4.335

6.  Among 10 sociodemographic and lifestyle variables, smoking is strongly associated with biomarkers of acrylamide exposure in a representative sample of the U.S. Population.

Authors:  Hubert W Vesper; Maya R Sternberg; Tunde Frame; Christine M Pfeiffer
Journal:  J Nutr       Date:  2013-04-17       Impact factor: 4.798

7.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

8.  Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.

Authors:  Lena Ernstgård; Margareta Warholm; Gunnar Johanson
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

9.  Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain.

Authors:  Kenneth P Cantor; Cristina M Villanueva; Debra T Silverman; Jonine D Figueroa; Francisco X Real; Monserrat Garcia-Closas; Nuria Malats; Stephen Chanock; Meredith Yeager; Adonina Tardon; Reina Garcia-Closas; Consol Serra; Alfredo Carrato; Gemma Castaño-Vinyals; Claudine Samanic; Nathaniel Rothman; Manolis Kogevinas
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

10.  In vitro inhibition of 10-formyltetrahydrofolate dehydrogenase activity by acetaldehyde.

Authors:  Ju-Ae Mun; Eunjin Doh; Hyesun Min
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.